Approval · Notice of Compliance 4956 · 1995
SUPRAX: Notice of Compliance 4956
Issued June 22, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4956
- Date
- June 22, 1995
- Company
- Wyeth-Ayerst Canada Inc.St. Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SUPRAX | 02170760 | — |
| SUPRAX | 02170787 | — |
| SUPRAX | 02170779 | — |